Palisade Bio Inc. buy Piper Sandler
Start price
29.12.25
/
50%
€0.34
Target price
29.12.26
€21.22
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 29.12.26. The prediction end date can be changed by Piper_Sandler at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Palisade Bio Inc. | - | - |
| iShares Core DAX® | 0,46 % | -1,53 % |
| iShares Nasdaq 100 | -1,79 % | -5,38 % |
| iShares Nikkei 225® | 5,12 % | 8,05 % |
| iShares S&P 500 | -1,76 % | -3,82 % |
Comments by Piper_Sandler for this prediction
In the thread Palisade Bio Inc. diskutieren
Palisade Bio (NASDAQ:PALI) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $25.00 price target on the stock.
Ratings data for PALI provided by MarketBeat